Skip to Main Content

Advertisement

Skip Nav Destination

Validation of TMEFF2 as a therapeutic target in bone metastasized prostate cancer and in in vivo models.

Cancer Res (2004) 64 (7_Supplement): 705–706.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal